- Home
- Applications
- phenotyping
Refine by
Phenotyping Product Applications
13 applications found
Use our platform to design antibodies that optimize binding affinity, titer, specific productivity, Immunogenicity, or other phenotypic variables of interest. Engineer antibodies that specifically kill cancer cells or equib cells with multiple functions, granting them the ability to invade human cancer-derived ...
ByTeselaGen Biotechnology, Inc. based in Portola Valley, CALIFORNIA (USA)
Radiance® provides new information around host response and the viral life cycle, enabling a better understanding of cellular infection through the measurement of novel phenotypic ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
Gene expression is the most fundamental level at which the genotype gives rise to a phenotype. Whether you have RNA-Seq, qPCR or microarray data, Partek provides easy-to-use tools that guide you through the analysis process from start to finish within a point-and-click interface. ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
Whole genome, exome, or targeted panel DNA sequencing (DNA-Seq) studies can identify genetic variants that contribute to disease and phenotypes. Partek offers powerful and easy-to-use tools for processing and analyzing your DNA sequencing data. ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link phenotype to gene ...
ByBruker Corporation based in Billerica, MASSACHUSETTS (USA)
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
These programs start with deep metagenomic and culture-based analysis of patient samples and involve advanced bioinformatics and machine learning, to identify highly significant bacterial signatures linked to phenotype. The signatures represent both biomarkers and Live Bacterial Therapeutics. ...
ByMicrobiotica Limited based in Little Chesterford, UNITED KINGDOM
Cyrus’s protein biochemistry capabilities include advanced selection methodologies in both yeast and mammalian cell systems. These tools can interrogate large numbers of mutations in cell surface receptors and many globular proteins, offering a unique path forward for protein optimization based on high quality, physiologically-relevant data in eukaryotic or – specifically – human ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
Real-time Viral Titer Assay Capability. Current viral titer assay methods, a crucial component of vaccine & CGT development and production efforts, are generally slow, labor intensive, subjective, and difficult to standardize, often resulting in large errors or failures during critical production ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
Introducing single-cell biopsy The novel non-invasive method for single-cell omics The novel method that keeps your cells alive during biopsy from single cells Single-cell omics addresses cellular heterogeneity head on by isolating and analyzing molecular components from individual cells. While many of the existing technologies rely on cell lysis — single-cell biopsy is the only non-invasive single-cell analysis method that allows researchers to take transcriptome snapshots of a ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
Locus has built an automated, generalizable platform that is systematically unlocking the power of bacteriophage and CRISPR-Cas3 across multiple therapeutic ...
ByLocus Biosciences, Inc. based in Morrisville, NORTH CAROLINA (USA)
Realize the value of global clinical and genomic data with us. We help reduce your risk, enhance your pipeline value and advance your enterprise data strategy by solving the barriers of data access and enabling rapid insight ...
ByBC Platforms based in Zürich, SWITZERLAND
Laser Force Cytology (LFC) and Radiance label-free approach to cell therapy research and biomanufacturing has significant value in expediting the process, decreasing costs, and ensuring therapy effectiveness and quality. Radiance enhances the highly complex biomanufacturing process for cell therapies by providing new insights to cell therapy research and process development. Current process development assays are fraught with difficult and time-consuming steps requiring highly skilled scientists and bioengineers ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)